Released: July 11, 2018
Pfizer buckles under pressure from Trump, delays drug price increases
Source: Damien Paletta, Washington Post (Paid Registration)
Pfizer chief executive Ian Read said late Tuesday that his company would delay increasing the prices of dozens of drug products after President Trump publicly berated the firm one day earlier.
The company, in a statement, said the price increases would effectively be postponed at least until the beginning of 2019 “to give the president an opportunity to work on his blueprint to strengthen the healthcare system and provide more access to patients.”
Read Full Article: Pfizer buckles under pressure from Trump, delays drug price increases
Search
Quick Menu
Consumer Help Desk
- Help Desk
- Submit Your Complaints
- Presente su queja
- Frequently Asked Questions
- Links to Consumer Resources
- Consumer Services Guide (CSG)
- Alerts
- Class Action Database
- Consumer Booknotes
Advocacy
- [email protected]
- California Action Center
- Position & Issues
- Legislative Positions
- Coalition Efforts
- On Our Radar